Condition: Bone Regeneration · Safety Issues · Sponsor: Wishbone SA
This investigation is a pre-market, prospective, multi-center, randomized, single blinded, parallel controlled clinical investigation performed in at least 5 clinical centers for confirmatory purposes of the use of WHA as intended in the filling of extraction sockets to enhance preservation of the alveolar socket.
This description comes directly from the study's public registry record.
Emilie Dory, CEO · +32484706172 · emilie.dory@wishbone-biotech.com
Justine Pirson, R&D Manager · +3249487202 · justine.pirson@wishbone-biotech.com
Always discuss trial participation with your own doctor first.
| Clinique de la Source DentalMe | Louvain-la-Neuve, Brabant Wallon, Belgium | Recruiting |
| Cabinet Debaty-Techy | Aubel, Liège, Belgium | Recruiting |
| Clinique du Faubourg DentalMe | Chaudfontaine, Liège, Belgium | Recruiting |
| Centre Hospitalier Université de Liège | Liège, Belgium | Recruiting |
| Centre Oxalys | Namur, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06383377